{"doi":"10.1101/2020.10.29.20222083","title":"Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study","abstract":"ABSTRACT Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments, and health outcomes among children/adolescents diagnosed or hospitalized with COVID-19. Secondly, to describe health outcomes amongst children/adolescents diagnosed with previous seasonal influenza. Design International network cohort. Setting Real-world data from European primary care records (France/Germany/Spain), South Korean claims and US claims and hospital databases. Participants Diagnosed and/or hospitalized children/adolescents with COVID-19 at age &lt;18 between January and June 2020; diagnosed with influenza in 2017-2018. Main outcome measures Baseline demographics and comorbidities, symptoms, 30-day in-hospital treatments and outcomes including hospitalization, pneumonia, acute respiratory distress syndrome (ARDS), multi-system inflammatory syndrome (MIS-C), and death. Results A total of 55,270 children/adolescents diagnosed and 3,693 hospitalized with COVID-19 and 1,952,693 diagnosed with influenza were studied. Comorbidities including neurodevelopmental disorders, heart disease, and cancer were all more common among those hospitalized vs diagnosed with COVID-19. The most common COVID-19 symptom was fever. Dyspnea, bronchiolitis, anosmia and gastrointestinal symptoms were more common in COVID-19 than influenza. In-hospital treatments for COVID-19 included repurposed medications (&lt;10%), and adjunctive therapies: systemic corticosteroids (6.8% to 37.6%), famotidine (9.0% to 28.1%), and antithrombotics such as aspirin (2.0% to 21.4%), heparin (2.2% to 18.1%), and enoxaparin (2.8% to 14.8%). Hospitalization was observed in 0.3% to 1.3% of the COVID-19 diagnosed cohort, with undetectable (N&lt;5 per database) 30-day fatality. Thirty-day outcomes including pneumonia, ARDS, and MIS-C were more frequent in COVID-19 than influenza. Conclusions Despite negligible fatality, complications including pneumonia, ARDS and MIS-C were more frequent in children/adolescents with COVID-19 than with influenza. Dyspnea, anosmia and gastrointestinal symptoms could help differential diagnosis. A wide range of medications were used for the inpatient management of pediatric COVID-19. What is already known on this topic? Most of the early COVID-19 studies were targeted at adult patients, and data concerning children and adolescents are limited. Clinical manifestations of COVID-19 are generally milder in the pediatric population compared with adults. Hospitalization for COVID-19 affects mostly infants, toddlers, and children with pre-existing comorbidities. What this study adds ⍰ This study comprehensively characterizes a large international cohort of pediatric COVID-19 patients, and almost 2 million with previous seasonal influenza across 5 countries. ⍰ Although uncommon, pneumonia, acute respiratory distress syndrome (ARDS) and multi-system inflammatory syndrome (MIS-C) were more frequent in children and adolescents diagnosed with COVID-19 than in those with seasonal influenza. ⍰ Dyspnea, bronchiolitis, anosmia and gastrointestinal symptoms were more frequent in COVID-19, and could help to differentiate pediatric COVID-19 from influenza. ⍰ A plethora of medications were used during the management of COVID-19 in children and adolescents, with great heterogeneity in the use of antiviral therapies as well as of adjunctive therapies.","journal":"medRxiv","year":2020,"id":118968,"datarank":0.5289540786924243,"base_score":3.5263605246161616,"endowment":3.5263605246161616,"self_citation_contribution":0.5289540786924243,"citation_network_contribution":0.0,"self_endowment_contribution":0.5289540786924243,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":33,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.534,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":258112,"name":"David Vizcaya","orcid":"0000-0003-0248-7636","position":1,"is_corresponding":false},{"id":32071,"name":"Andrea Pistillo","orcid":"0000-0002-4467-0220","position":2,"is_corresponding":false},{"id":258092,"name":"Paula Casajust","orcid":"0000-0003-2733-5436","position":3,"is_corresponding":false},{"id":32056,"name":"Anthony G. Sena","orcid":"0000-0001-8630-5347","position":4,"is_corresponding":false},{"id":32051,"name":"Lana Yin Hui Lai","orcid":"0000-0002-0485-0956","position":5,"is_corresponding":false},{"id":258108,"name":"Albert Prats‐Uribe","orcid":"0000-0003-1202-9153","position":6,"is_corresponding":false},{"id":552594,"name":"Waheed‐Ul‐Rahman Ahmed","orcid":"0000-0003-0880-0355","position":7,"is_corresponding":false},{"id":32109,"name":"Thamir M. Alshammari","orcid":"0000-0002-5630-2468","position":8,"is_corresponding":false},{"id":258088,"name":"Heba Alghoul","orcid":"0000-0001-8234-5843","position":9,"is_corresponding":false},{"id":258089,"name":"Osaid Alser","orcid":"0000-0001-6743-803X","position":10,"is_corresponding":false},{"id":258091,"name":"Edward Burn","orcid":"0000-0002-9286-1128","position":11,"is_corresponding":false},{"id":258115,"name":"Seng Chan You","orcid":"0000-0002-5052-6399","position":12,"is_corresponding":false},{"id":266938,"name":"Carlos Areia","orcid":"0000-0002-4668-7069","position":13,"is_corresponding":false},{"id":32052,"name":"Clair Blacketer","orcid":"0000-0003-2570-2124","position":14,"is_corresponding":false},{"id":11351,"name":"Scott L. DuVall","orcid":"0000-0002-4898-3865","position":15,"is_corresponding":false},{"id":266935,"name":"Thomas Falconer","orcid":"0000-0001-6904-1394","position":16,"is_corresponding":false},{"id":258095,"name":"Sergio Fernández‐Bertolín","orcid":"0000-0002-0029-6564","position":17,"is_corresponding":false},{"id":552595,"name":"Stephen Fortin","orcid":"0000-0001-7529-8890","position":18,"is_corresponding":false},{"id":277989,"name":"Asieh Golozar","orcid":"0000-0002-4243-155X","position":19,"is_corresponding":false},{"id":552596,"name":"Mengchun Gong","orcid":"0000-0001-8197-6643","position":20,"is_corresponding":false},{"id":552597,"name":"Eng Hooi Tan","orcid":"0000-0003-4470-2736","position":21,"is_corresponding":false},{"id":63963,"name":"Vojtech Huser","orcid":"0000-0002-0709-6573","position":22,"is_corresponding":false},{"id":552598,"name":"Pablo Iveli","orcid":"0000-0001-5074-6626","position":23,"is_corresponding":false},{"id":32063,"name":"Daniel R. Morales","orcid":"0000-0002-0063-8069","position":24,"is_corresponding":false},{"id":32103,"name":"Fredrik Nyberg","orcid":"0000-0003-0892-5668","position":25,"is_corresponding":false},{"id":32113,"name":"Jose Posada","orcid":"0000-0003-3864-0241","position":26,"is_corresponding":false},{"id":552599,"name":"Martina Recalde","orcid":"0000-0003-2256-618X","position":27,"is_corresponding":false},{"id":32070,"name":"Elena Roel","orcid":"0000-0002-1964-3546","position":28,"is_corresponding":false},{"id":277997,"name":"Lisa M. Schilling","orcid":"0000-0002-6878-189X","position":29,"is_corresponding":false},{"id":226836,"name":"Nigam H. Shah","orcid":"0000-0001-9385-7158","position":30,"is_corresponding":false},{"id":552600,"name":"Karishma Shah","orcid":"0000-0002-6219-1653","position":31,"is_corresponding":false},{"id":32104,"name":"Marc A. Suchard","orcid":"0000-0001-9818-479X","position":32,"is_corresponding":false},{"id":258116,"name":"Lin Zhang","orcid":"0000-0002-2064-8440","position":33,"is_corresponding":false},{"id":552601,"name":"Ying Zhang","orcid":"0000-0002-5885-0214","position":34,"is_corresponding":false},{"id":225276,"name":"Andrew E. Williams","orcid":"0000-0002-0692-412X","position":35,"is_corresponding":false},{"id":32077,"name":"Christian Reich","orcid":"0000-0002-3641-055X","position":36,"is_corresponding":false},{"id":2010,"name":"George Hripcsak","orcid":"0000-0003-2664-7614","position":37,"is_corresponding":false},{"id":553315,"name":"Peter Rijnbeek","orcid":null,"position":38,"is_corresponding":false},{"id":32122,"name":"Patrick Ryan","orcid":"0000-0002-9727-2138","position":39,"is_corresponding":false},{"id":225287,"name":"Kristin Kostka","orcid":"0000-0003-2595-8736","position":40,"is_corresponding":false},{"id":32121,"name":"Daniel Prieto‐Alhambra","orcid":"0000-0002-3950-6346","position":41,"is_corresponding":false},{"id":32111,"name":"Talita Duarte‐Salles","orcid":"0000-0002-8274-0357","position":0,"is_corresponding":true}],"reference_count":22,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:14:03.409507Z","pmid":"33140074","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}